4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

C40H55NO4S — CID 145082069

IUPAC4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESCC1(C)C(c2ccc(C(=O)O)cc2)=CC[C@@]2(C)C1CC[C@]1(C)C2CC[C@@H]2[C@H]3CCC[C@]3(/C=C/C(=O)N3CCS(=O)CC3)CC[C@]21C
InChIInChI=1S/C40H55NO4S/c1-36(2)29(27-8-10-28(11-9-27)35(43)44)14-18-37(3)32(36)15-19-39(5)33(37)13-12-30-31-7-6-17-40(31,22-21-38(30,39)4)20-16-34(42)41-23-25-46(45)26-24-41/h8-11,14,16,20,30-33H,6-7,12-13,15,17-19,21-26H2,1-5H3,(H,43,44)/b20-16+/t30-,31-,32?,33?,37+,38-,39-,40+/m1/s1
InChIKeyRWFWJPBCWKLGCA-QWYBKSGUSA-N
MW645.95 g/mol
LogP8.38
Rot. Bonds4

About 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 145082069) has the molecular formula C40H55NO4S and a molecular weight of 645.95 g/mol. Its IUPAC name is 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.

Molecular Properties

Compound Name4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
PubChem CID145082069
Molecular FormulaC40H55NO4S
Molecular Weight645.95 g/mol
Exact Mass645.39
IUPAC Name4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESCC1(C)C(c2ccc(C(=O)O)cc2)=CC[C@@]2(C)C1CC[C@]1(C)C2CC[C@@H]2[C@H]3CCC[C@]3(/C=C/C(=O)N3CCS(=O)CC3)CC[C@]21C
InChIInChI=1S/C40H55NO4S/c1-36(2)29(27-8-10-28(11-9-27)35(43)44)14-18-37(3)32(36)15-19-39(5)33(37)13-12-30-31-7-6-17-40(31,22-21-38(30,39)4)20-16-34(42)41-23-25-46(45)26-24-41/h8-11,14,16,20,30-33H,6-7,12-13,15,17-19,21-26H2,1-5H3,(H,43,44)/b20-16+/t30-,31-,32?,33?,37+,38-,39-,40+/m1/s1
InChIKeyRWFWJPBCWKLGCA-QWYBKSGUSA-N
XLogP8.38
TPSA74.68 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500645.95
LogP ≤ 58.38
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The IUPAC name of 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (CID 145082069) is 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.
What is the SMILES notation for 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The canonical SMILES for 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is CC1(C)C(c2ccc(C(=O)O)cc2)=CC[C@@]2(C)C1CC[C@]1(C)C2CC[C@@H]2[C@H]3CCC[C@]3(/C=C/C(=O)N3CCS(=O)CC3)CC[C@]21C.
What is the InChIKey of 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The InChIKey is RWFWJPBCWKLGCA-QWYBKSGUSA-N. The full InChI is InChI=1S/C40H55NO4S/c1-36(2)29(27-8-10-28(11-9-27)35(43)44)14-18-37(3)32(36)15-19-39(5)33(37)13-12-30-31-7-6-17-40(31,22-21-38(30,39)4)20-16-34(42)41-23-25-46(45)26-24-41/h8-11,14,16,20,30-33H,6-7,12-13,15,17-19,21-26H2,1-5H3,(H,43,44)/b20-16+/t30-,31-,32?,33?,37+,38-,39-,40+/m1/s1.
What are the key properties of 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid has a molecular weight of 645.95 g/mol, XLogP of 8.38, 4 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(3aR,5aR,5bR,11aS,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-3a-[(E)-3-oxo-3-(1-oxo-1,4-thiazinan-4-yl)prop-1-enyl]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is sourced from PubChem (CID 145082069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).